These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21586620)

  • 1. GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt.
    Goerlitz D; El Daly M; Abdel-Hamid M; Saleh DA; Goldman L; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Zaghloul MS; Ali SR; Khaled H; Amr S; Zheng YL; Mikhail N; Loffredo C
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1552-4. PubMed ID: 21586620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer.
    Abdel-Rahman SZ; Anwar WA; Abdel-Aal WE; Mostafa HM; Au WW
    Cancer Detect Prev; 1998; 22(2):129-38. PubMed ID: 9544433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.
    Srivastava DS; Kumar A; Mittal B; Mittal RD
    Arch Toxicol; 2004 Aug; 78(8):430-4. PubMed ID: 15057507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.
    Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA
    Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
    Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
    Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
    Yu C; Hequn C; Longfei L; Long W; Zhi C; Feng Z; Jinbo C; Chao L; Xiongbing Z
    Oncotarget; 2017 Jan; 8(2):3246-3258. PubMed ID: 27911277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between GSTM1 and GSTT1 polymorphisms and esophageal squamous cell carcinoma: results from a case-control study in Kashmir, India.
    Makhdoomi MA; Shah IA; Bhat GA; Amin S; Lone MM; Islami F; Dar NA
    Tumour Biol; 2015 Apr; 36(4):2613-9. PubMed ID: 25432134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population.
    Törüner GA; Akyerli C; Uçar A; Aki T; Atsu N; Ozen H; Tez M; Cetinkaya M; Ozçelik T
    Arch Toxicol; 2001 Oct; 75(8):459-64. PubMed ID: 11757669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study.
    Georgiou I; Filiadis IF; Alamanos Y; Bouba I; Giannakopoulos X; Lolis D
    Eur Urol; 2000 Jun; 37(6):660-4. PubMed ID: 10828664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population.
    Ouerhani S; Tebourski F; Slama MR; Marrakchi R; Rabeh M; Hassine LB; Ayed M; Elgaaïed AB
    Ann Hum Biol; 2006; 33(5-6):529-35. PubMed ID: 17381051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer.
    Kang HW; Tchey DU; Yan C; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Kim IY; Kim WJ
    Urol Oncol; 2014 May; 32(4):458-65. PubMed ID: 24411789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
    El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
    Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.
    Karagas MR; Park S; Warren A; Hamilton J; Nelson HH; Mott LA; Kelsey KT
    Cancer Lett; 2005 Feb; 219(1):63-9. PubMed ID: 15694665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population.
    Kucukgergin C; Sanli O; Amasyalı AS; Tefik T; Seckin S
    Med Oncol; 2012 Sep; 29(3):1928-34. PubMed ID: 21904836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.